Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA
Trial details
- Registry ID
- NCT05667662
- Drugs studied
- Itraconazole Powder
TrialRedline tracks 1 clinical trial sponsored by Pulmatrix Inc.: 1 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPANCT05667662 | Itraconazole Powder | Terminated | 2024-02-27Actual |
Names as written in the registry records.